These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25363547)

  • 41. Metformin: Current knowledge.
    Nasri H; Rafieian-Kopaei M
    J Res Med Sci; 2014 Jul; 19(7):658-64. PubMed ID: 25364368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diabetes mellitus and malignancies].
    Petera J; Smahelová A
    Vnitr Lek; 2014; 60 Suppl 2():69-74. PubMed ID: 25389098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Albiglutide for the treatment of type 2 diabetes.
    Muscogiuri G; Gastaldelli A
    Drugs Today (Barc); 2014 Oct; 50(10):665-78. PubMed ID: 25374965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes.
    Blüher M; Schweizer A; Bader G; Foley JE
    Vasc Health Risk Manag; 2014; 10():661-4. PubMed ID: 25429228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: HARMONY 5.
    Home PD; Shamanna P; Stewart M; Yang F; Miller M; Perry C; Carr MC
    Diabetes Obes Metab; 2015 Feb; 17(2):179-87. PubMed ID: 25406730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes.
    Peene B; Benhalima K
    Ther Adv Endocrinol Metab; 2014 Oct; 5(5):124-36. PubMed ID: 25419452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The durability of sitagliptin in elderly patients with type 2 diabetes.
    Hsieh CJ; Shen FC
    Clin Interv Aging; 2014; 9():1905-11. PubMed ID: 25422588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.
    Della-Morte D; Palmirotta R; Rehni AK; Pastore D; Capuani B; Pacifici F; De Marchis ML; Dave KR; Bellia A; Fogliame G; Ferroni P; Donadel G; Cacciatore F; Abete P; Dong C; Pileggi A; Roselli M; Ricordi C; Sbraccia P; Guadagni F; Rundek T; Lauro D
    Pharmacogenomics; 2014 Dec; 15(16):2063-82. PubMed ID: 25521362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre study.
    Maréchaux S; Rusinaru D; Jobic Y; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Jeu A; Szymanski C; Tribouilloy C
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):158-65. PubMed ID: 25368209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
    Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
    J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Varenicline and abnormal sleep related events.
    Savage RL; Zekarias A; Caduff-Janosa P
    Sleep; 2015 May; 38(5):833-7. PubMed ID: 25409105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Local treatment of osteoporosis with alendronate-loaded calcium phosphate cement.
    Zhao J; Tang H; Wang J; Li G
    Chin Med J (Engl); 2014; 127(22):3906-14. PubMed ID: 25421189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cost-effectiveness and budget impact of ivabradine in heart failure therapy].
    Polistena B; Maggioni AP; Oliva F; Spandonaro F
    G Ital Cardiol (Rome); 2014 Nov; 15(11):626-33. PubMed ID: 25424141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Helicobacter pylori infection decreases metformin tolerance in patients with type 2 diabetes mellitus.
    Huang Y; Sun J; Wang X; Tao X; Wang H; Tan W
    Diabetes Technol Ther; 2015 Feb; 17(2):128-33. PubMed ID: 25391019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of lercanidipine versus amlodipine in hypertensive patients with cerebral ischemic stroke.
    Cao TS; Huynh VM; Tran VH
    Curr Med Res Opin; 2015 Jan; 31(1):163-70. PubMed ID: 25425058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aliskiren in an alternate-day administration schedule in hypertensive albuminuric patients.
    Spanos G; Kalaitzidis RG; Karasavvidou DP; Zikou X; Siamopoulos KC
    Blood Press Monit; 2014 Dec; 19(6):359-65. PubMed ID: 25369821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vortioxetine (Brintellix®) and levomilnacipran (Fetzima®): the two newest additions to the antidepressant formulary.
    Roman MW; Wilkinson SM
    Issues Ment Health Nurs; 2014 Dec; 35(12):972-4. PubMed ID: 25426751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fixed-dose combination therapy in type 2 diabetes mellitus.
    Blonde L; San Juan ZT; Bolton P
    Endocr Pract; 2014 Dec; 20(12):1322-32. PubMed ID: 25370323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aripiprazole combined with other psychotropic drugs in pregnancy: two case reports.
    Pirec V; Mehta A; Shoush S
    Isr J Psychiatry Relat Sci; 2014; 51(2):135-6. PubMed ID: 25372563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis.
    Levin D; Bell S; Sund R; Hartikainen SA; Tuomilehto J; Pukkala E; Keskimäki I; Badrick E; Renehan AG; Buchan IE; Bowker SL; Minhas-Sandhu JK; Zafari Z; Marra C; Johnson JA; Stricker BH; Uitterlinden AG; Hofman A; Ruiter R; de Keyser CE; MacDonald TM; Wild SH; McKeigue PM; Colhoun HM; ;
    Diabetologia; 2015 Mar; 58(3):493-504. PubMed ID: 25481707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.